The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study

被引:75
|
作者
Graff-Guerrero, Ariel [1 ,2 ,3 ]
Mizrahi, Romina [1 ,2 ]
Agid, Ofer [1 ,2 ]
Marcon, Heidi [1 ]
Barsoum, Penny [1 ]
Rusjan, Pablo [1 ]
Wilson, Alan A. [1 ,2 ]
Zipursky, Robert [2 ,4 ,5 ]
Kapur, Shitij [1 ,2 ,6 ]
机构
[1] Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
[3] Univ Nacl Autonoma Mexico, Inst Neurobiol, Juriquilla, Queretaro, Mexico
[4] McMaster Univ, Dept Psychiat, Hamilton, ON L8S 4L8, Canada
[5] McMaster Univ, Dept Behav Neurosci, Hamilton, ON L8S 4L8, Canada
[6] Kings Coll London, Inst Psychiat, London SE5 8AF, England
基金
加拿大健康研究院;
关键词
schizophrenia; psychosis; C-11]-(+)-PHNO; D-3; D-2; high-affinity state; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; ENDOGENOUS DOPAMINE; AGONIST RADIOLIGAND; D2(HIGH) RECEPTORS; D-2/3; AGONIST; BINDING; AMPHETAMINE; RADIOTRACER; BRAIN;
D O I
10.1038/npp.2008.199
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The dopamine D-2 receptors exist in two states: a high-affinity state (D-2(high)) that is linked to second messenger systems, is responsible for functional effects, and exhibits high affinity for agonists; and a low-affinity state that is functionally inert and exhibits lower affinity for agonists. The dopamine D-3 receptors have high-affinity for agonist (eg dopamine) and the existence of the two affinity states is controversial. Although preclinical studies in animal models of psychosis have shown a selective increase of D-2(high) as the common pathway to psychosis, the D-3 has been suggested to be involved in the pathophysiology of psychosis. We report the first study of the D-2(high) and D-3 in schizophrenia using the novel PET radiotracer, [C-11]-(+)- PHNO. We recruited 13 patients with schizophrenia-spectrum disorder amidst an acute psychotic episode, drug free for at least 2 weeks, and 13 age - sex-matched healthy controls. The binding potential no-displaceable (BPND) was examine in the main regions of interest (caudate, putamen, ventral striatum, globus pallidus, substantia nigra, and anterior thalamus) and in a voxel-wise analysis. The BPND between patients and controls was not different in any of the regions. The voxel-wise analysis did not reveal any difference and no correlations were found between the BPND and positive and negative syndrome scale subscales. Our results do not find support for the hypothesis linking psychosis to a selective increase in D-2(high) and/or D-3 in schizophrenia. It is possible that receptors with high affinity are not accessible by [C-11]-(+)-PHNO because they are occupied by endogenous dopamine, a possibility that can be ruled out in future experiments.
引用
收藏
页码:1078 / 1086
页数:9
相关论文
共 50 条
  • [21] Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO
    Mark Slifstein
    Anissa Abi-Dargham
    Ragy R Girgis
    Raymond F Suckow
    Thomas B Cooper
    Chaitanya R Divgi
    Pierre Sokoloff
    Ludovic Leriche
    Patrick Carberry
    Shunichi Oya
    Simon K Joseph
    Marlène Guiraud
    Agnès Montagne
    Valérie Brunner
    Florence Gaudoux
    Françoise Tonner
    Psychopharmacology, 2020, 237 : 519 - 527
  • [22] Differential Effects of Stress on [11C]Raclopride and [11C] MNPA Binding to Striatal D2/D3 Dopamine Receptors: A PET Study in Conscious Monkeys
    Tsukada, Hideo
    Ohba, Hiroyuki
    Nishiyama, Shingo
    Kakiuchi, Takeharu
    SYNAPSE, 2011, 65 (01) : 84 - 89
  • [23] Occupancy of dopamine D2 and D3 receptors by a novel D3 partial agonist BP1.4979: a [11C]-(+)-PHNOPET study in humans
    Di Ciano, Patricia
    Mansouri, Esmaeil
    Tong, Junchao
    Wilson, Alan A.
    Houle, Sylvain
    Boileau, Isabelle
    Duvauchelle, Thierry
    Robert, Philippe
    Schwartz, Jean Charles
    Le Foll, Bernard
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (07) : 1284 - 1290
  • [24] Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study
    Chukwueke, Chidera C.
    Nona, Christina N.
    McPhee, Matthew D.
    Mansouri, Esmaeil
    Rubin-Kahana, Dafna S.
    Martinez, Diana
    Boileau, Isabelle
    Hendershot, Christian S.
    Le Foll, Bernard
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (12) : 2112 - 2120
  • [25] The Dopamine Stabilizer (-)-OSU6162 Occupies a Subpopulation of Striatal Dopamine D2/D3 Receptors: An [11C] Raclopride PET Study in Healthy Human Subjects
    Tolboom, Nelleke
    Berendse, Henk W.
    Leysen, Josee E.
    Yaqub, Maqsood
    van Berckel, Bart N. M.
    Schuit, Robert C.
    Ponsen, Mirthe M.
    Bakker, Esther
    Hoetjes, Nikie J.
    Windhorst, Albert D.
    Carlsson, Maria L.
    Lammertsma, Adriaan A.
    Carlsson, Arvid
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (02) : 472 - 479
  • [26] Parametric Imaging and Test-Retest Variability of 11C-(+)-PHNO Binding to D2/D3 Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner
    Gallezot, Jean-Dominique
    Zheng, Ming-Qiang
    Lim, Keunpoong
    Lin, Shu-fei
    Labaree, David
    Matuskey, David
    Huang, Yiyun
    Ding, Yu-Shin
    Carson, Richard E.
    Malison, Robert T.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (06) : 960 - 966
  • [27] Evaluation of dopamine D3 receptor occupancy by blonanserin using [11C]-(+)-PHNO in schizophrenia patients
    Sakayori, Takeshi
    Tateno, Amane
    Arakawa, Ryosuke
    Kim, Woo-chan
    Okubo, Yoshiro
    PSYCHOPHARMACOLOGY, 2021, 238 (05) : 1343 - 1350
  • [28] Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [11C]-(+)-PHNO
    Girgis, Ragy R.
    Xu, Xiaoyan
    Gil, Roberto B.
    Hackett, Elizabeth
    Ojeil, Najate
    Lieberman, Jeffrey A.
    Slifstein, Mark
    Abi-Dargham, Anissa
    SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) : 373 - 376
  • [29] Dopamine D2 and D3 Receptor Availability in Antipsychotic-free patients with Schizophrenia in Later Life: A Cross-sectional [11C]-(+)-PHNO and [11C]-raclopride PET Study
    Nakajima, Shinichiro
    Caravaggio, Fernando
    Mamo, David C.
    Mulsant, Benoit H.
    Chung, Jun Ku
    Plitman, Eric
    Iwata, Yusuke
    Gerretsen, Philip
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Mar, Wanna
    Wilson, Alan A.
    Houle, Sylvain
    Graff-Guerrero, Ariel
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 118S - 118S
  • [30] D3 receptor target engagement in humans with ABT-925 using [11C](+)-PHNO PET - a response
    Day, Mark
    Bain, Earle
    Marek, Gerard
    Saltarelli, Mario
    Fox, Gerard B.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (03): : 291 - 292